Application of FXYD3 as gastric cancer diagnosis marker and treatment target
A diagnostic marker and marker technology, applied in the field of medical biological detection, can solve the problems of few reports and unclear effects, and achieve the effects of inhibiting the formation of intratumoral blood vessels and enhancing the sensitivity of chemotherapeutic drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0052] Gastric cancer tissues and adjacent normal tissues were obtained from patients who came to the hospital for surgical treatment; gastric cancer cell lines AGS, BGC-823, MGC-803, MKN-45 and normal gastric epithelial cell line EGS1 were all treated with DMEM containing 10% FBS (high Sugar) medium, cultured at 37°C, 5% CO2 and 95% humidity; BALB / c nude mice, 5 weeks old, were raised in an SPF environment.
[0053] (1) qPCR
[0054] Tissue and cell samples were collected, total RNA was extracted, and reverse transcribed into cDNA. The primer sequences of the designed and synthesized FXYD3 gene and the internal reference GAPDH gene are as follows:
[0055] FXYD3-F:5'-GCCCAAAGCTGATGAGGACAGAC-3',
[0056] FXYD3-R:5'-GAGTCCCCAGCAGAGGAGGAAGAA-3';
[0057] GAPDH-F: 5'-ATGACATCAAGAAGGTGGTGAAGCAGG-3',
[0058] GAPDH-R: 5'-GCGTCAAAGGTGGAGGAGTGGGT-3'.
[0059] The amplification conditions are as follows: 95°C for 1min; 95°C for 10s, 60°C for 30s, 40cycles. Sequence Detectionsoft...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com